Retatrutide
Triple receptor agonist
$140In Stock
For research use only — not for human consumption.
Overview
Retatrutide is a novel triple receptor agonist that targets GLP-1, GIP, and glucagon receptors. This research compound has been studied for its potential applications in metabolic research.